tures, we have demonstrated that the later structural
unit can be incorporated into a cyclic peptide obtainable
by ring closing metathesis. Thus the presence of the
known transition state analogue in the cyclic peptide may
make them interesting as potential HIV protease inhibi-
tors. It was reasoned that the tripeptides derived from
sequence where L-proline is in the γ-turn forming i+1
position6 would be an ideal precursor for such cycliza-
tions. This assumption was vindicated as we had shown
that the ring closing metathesis on a tripeptide such as
O-allyl-Xaa-L-proline-â-phenylisoserine-N-allyl 1a (Fig-
ure 1) led to cyclic peptide 2a . We proposed that this
cyclization was dictated by the presence of a γ-turn that
was supported by the fact that tripeptides 1b, consisting
of L-proline residue in the i+2 position, did not yield any
corresponding cyclic peptide on ring closing metathesis.
Clearly the tripeptide 1b lacks the intramolecular hy-
drogen bond and this led us to believe that the preorga-
nization of such structures may be a necessary condition
for ring closing metathesis. To assess the role of the
intramolecular hydrogen bond in these cyclizations, we
have further carried out studies on acyclic peptides
capable of forming an intramolecular ten-membered
hydrogen bond, i.e., a â-turn, and a detailed account of
these findings is given below.
The design of these cyclic peptides is based upon the
concept of mimicking the bioactive conformation by
introducing constraints in the flexible molecules through
their cyclization. We now show that tripeptides 3 derived
from O-allyl-Xaa-L-proline-â-phenylisoserine-N-allyl or
O-allyl-L-proline-Xaa-â-phenylisoserine-N-allyl deriva-
tives are preorganized due to γ- or â-turn and can be
cyclized by ring closing metathesis (Scheme 1 and 2) with
Grubbs’ catalyst.3a It is also demonstrated that irrespec-
tive of the position of L-proline in the tripeptide, the
cyclization is facile only when a γ- or â-turn is present
in such structures. The precursor peptides 3a -d were
prepared from N-cinnamoyl amino acids by conventional
coupling, using mixed anhydride protocol followed by O-
or N-allylation of the C-terminal end of the resulting
peptides.
Syn th esis of Sm a ll Cyclic P ep tid es via
Rever se Tu r n In d u ced Rin g Closin g
Meta th esis of Tr ip ep tid es
E. N. Prabhakaran,† I. Nageswara Rao,‡
Anima Boruah,‡ and J aved Iqbal*,†,‡,§
Department of Chemistry, Indian Institute of Technology,
Kanpur 208 016, India, and Discovery Research,
Dr. Reddy’s Laboratories Ltd., Miyapur,
Hyderabad 500 050, India
javediqbaldrf@hotmail.com
Received J anuary 15, 2002
Abstr a ct: A reverse turn induced (γ/â-turn) cyclization of
tripeptides 1 can be performed in a ring closing metathesis
reaction with Grubbs’ catalyst to the corresponding cyclic
peptides 2. These cyclic peptides may be useful probes as a
conformationally constrained mimic of the bioactive confor-
mation of structurally related HIV protease inhibitors.
The synthesis and screening of huge peptide libraries
has led to the emergence of small peptides as important
lead structures for the development1 of potential thera-
peutic agents. It is known that the linear peptide frag-
ments are flexible and exhibit numerous conformations
in solution; however, if one can restrict the conforma-
tional freedom of these linear peptides by introducing2
some constraints in the structure, it may render a bio-
logically active peptide more potent, more specific, and
orally active and this may give rise to species which are
therapeutically useful. Thus, small cyclic peptides are of
great interest for the elucidation of bioactive conforma-
tions due to their restricted conformational flexibility. In
view of the importance of constrained conformations,
there have been several attempts3 to lock peptides into
turn configurations and to synthesize molecules that
might mimic a reverse turn present in proteins. Several
types of turns are found and among them the type I and
type II â-turns are most commonly observed in protein
secondary structures. Therefore the understanding of the
conformation of type I and II â-turn is very crucial to the
development of inhibitors of HIV protease.4
These tripeptides were found to exist as preorganized
structures due to the presence of a γ- or â-turn formed
by intramolecular hydrogen bonds. The presence of the
In a previous communication5 relating to the work on
the search for HIV protease inhibitors based on pyrroli-
dine-containing R-hydroxy â-amino amide core struc-
1
intramolecular hydrogen bond was studied by H NMR
of the tripeptides 3a -d in dilute CDCl3 solution in the
presence of different concentrations of DMSO-d6. The
δNHa and δNHb in 3a and 3b indicate (Table 1) that these
amide protons appear at lower field as compared to δNHa
for 3d , suggesting a possible intramolecular hydrogen
† Indian Institute of Technology.
‡ Discovery Research, Dr. Reddy’s Laboratories Ltd.
§ Present Address: Director, Regional Research Laboratory, Trivan-
drum, India 695 019.
(1) (a) Thompson, L. A.; Ellman, J . A. Chem Rev., 1996, 96, 555. (b)
Fruchtel, J . S.; J ung, G. Angew. Chem., Int. Ed. Engl. 1996, 35, 17. (c)
Terrett, N. K.; Gardner, M.; Gordon, D. W.; Kobylecki, R. J .; Steele, J .
Tetrahedron, 1995, 51, 8135.
(2) For â-turn see: (a) Ball, J . B.; Hughes, R. A.; Alewood, P. L.;
Andrews, P. R. Tetrahedron 1993, 49, 3467 and references therein.
(b) Haubner, R.; Finsinger, D.; Kessler, H. Angew. Chem., Int. Ed. Engl.
1997, 36, 1375. (c) Kim. K.; Germanas, J . P. J . Org. Chem. 1997, 62,
2853. (d) J ones, I. G.; J ones, W.; North, M. J . Org. Chem. 1998, 63,
1505. (e) Krauthauser, S.; Christianson, L. A.; Powell, D. R.; Gellman,
S. H. J . Am. Chem. Soc. 1997, 119, 11719.
(4) (a) Slee, D. H.; Laslo, K. L.; Elder, J . H.; Ollmann, I. R.;
Gustchina, A.; Kervinen, J .; Zdanov, A.; Wlodawer, A.; Wong, C. J .
Am. Chem. Soc. 1995, 117, 11867. (b) Lam, P. Y. S.; J adhav, P. K.;
Eyermann, C. J .; Hodge, C. N.; Ru, Y.; Bacheler, L. T.; Meek, J . L.;
Otto, M. J .; Rayner, M. M.; Wong, Y. N.; Chang, C.-H.; Weber, P. C.;
J ackson, D. A.; Sharpe, T. R.; Erickson-Viitanen, S. Science 1994, 263,
380.
(5) (a) Prabhakaran, E. N.; Nandy, J . P.; Shukla, S.; Iqbal, J .
Tetrahedron Lett. 2001, 42, 333. (b) Prabhakaran, E. N.; Rajesh, V.;
Dubey, S.; Iqbal, J . Tetrahedron Lett. 2001, 42, 339.
(3) (a) Miller, S. J .; Blackwell, H. E.; Grubbs, R. H. J . Am. Chem.
Soc. 1996, 118, 9606. (b) Fink, B. E.; Kym, P. R.; Katzenellenbogen, J .
A. J . Am. Chem. Soc. 1998, 120, 4334. (c) Li, W.; Burgess, K.
Tetrahedron Lett. 1999, 40, 6527.
(6) For the turn-inducing role of proline in the cyclization of small
peptides see: Sager, C.; Mutter, M.; Dumy, P. Tetrahedron Lett. 1999,
40, 7987.
10.1021/jo0200320 CCC: $22.00 © 2002 American Chemical Society
Published on Web 10/25/2002
J . Org. Chem. 2002, 67, 8247-8250
8247